QuanDruPlex
- Biotech or pharma, therapeutic R&D
QuanDruPlex Inc. is developing a quantum-enhanced simulation platform to optimize drug delivery formulations, with an initial focus on nanoparticle-based therapeutics. QuanDruPlex’s proprietary platform (provisional patent pending) encodes biologically relevant modifiers into quantum simulation circuits to optimize delivery formulations across renal, liver, and CNS applications. Specific encoding strategies and circuit architectures are under patent protection and not disclosed here.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}